Q4 2025 Holdings
Filed 2026-02-17 | 45 holdings | $565.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-09-02) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences Inc(GILD) | COM | 375558103 | $35.5M | 289,312 | 6.3% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $34.9M | 647,899 | 6.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $34.4M | 360,428 | 6.1% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $31.4M | 410,700 | 5.6% |
| Bridgebio Pharma Inc(BBIO)A | COM | 10806X102 | $31.4M | 410,700 | 5.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $27.9M | 25,923 | 4.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $26.9M | 653,572 | 4.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $25.4M | 119,265 | 4.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $25.1M | 1,196,807 | 4.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $25.0M | 120,840 | 4.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $23.0M | 29,797 | 4.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $17.6M | 252,901 | 3.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $16.7M | 360,340 | 2.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.4M | 258,381 | 2.9% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $15.9M | 187,048 | 2.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $15.4M | 27,209 | 2.7% |
| Natera Inc(NTRA) | COM | 632307104 | $14.3M | 62,273 | 2.5% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $13.3M | 821,195 | 2.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $13.3M | 98,514 | 2.3% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $12.8M | 257,465 | 2.3% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $12.1M | 5,491,866 | 2.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $12.0M | 331,849 | 2.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $11.6M | 698,996 | 2.0% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.3M | 564,461 | 1.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $10.2M | 156,109 | 1.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $10.2M | 519,715 | 1.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $8.8M | 110,427 | 1.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $8.7M | 714,501 | 1.5% |
| Septerna Inc(SEPN) | COM | 81734D104 | $8.2M | 294,360 | 1.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.7M | 1,446,254 | 1.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.9M | 288,345 | 1.2% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $6.7M | 267,058 | 1.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $5.5M | 136,958 | 1.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $3.7M | 162,550 | 0.7% |
| Heartflow Inc(HTFL) | COM | 42238D107 | $3.3M | 113,857 | 0.6% |
| Grail Inc(GRAL) | COM | 384747101 | $2.6M | 30,313 | 0.5% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $2.3M | 201,301 | 0.4% |
| Billiontoone Inc(BLLN) | CL A | 090168105 | $2.1M | 25,505 | 0.4% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $1.9M | 1,259,820 | 0.3% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.3M | 1,320,041 | 0.2% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $1.1M | 10,452 | 0.2% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $1.1M | 142,984 | 0.2% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $857.0K | 528,993 | 0.2% |
| Atai Beckley NV | SHS | N0731H103 | $805.1K | 196,858 | 0.1% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $438.8K | 118,279 | 0.1% |
| Sensei Biotherapeutics Inc(SNSE) | COM NEW | 81728A207 | $157.0K | 14,718 | 0.0% |